Michael Plopper
San Diego, CANPI 1427121524
Payments from drug & device makers
Across 520 payments — averaging $14,032 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$3.9M
- Eli Lilly$2.5M
- Janssen Scientific Affairs, LLC$400K
- Novo Nordisk AS$124K
- UCB SA$107K
- Janssen Research & Development, LLC$106K
- plus $151K from 9 others
Across 5 payments — averaging $2064.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$10K
- AbbVie$361
What the payments were for
- Speaking & faculty fees$27,75074%
- Travel & lodging$8,23722%
- Food & beverage$1,5084%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 343 | $3,941,067 |
| Eli Lilly | 27 | $2,467,109 |
| Janssen Scientific Affairs, LLC | 2 | $400,056 |
| Novo Nordisk AS | 38 | $123,752 |
| UCB SA | 8 | $107,297 |
| Janssen Research & Development, LLC | 9 | $106,373 |
| Johnson & Johnson | 48 | $36,107 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $33,746 |
| Biogen | 5 | $33,079 |
| AbbVie | 20 | $25,360 |
| Teva Pharmaceuticals USA, Inc. | 4 | $9,000 |
| Alkermes, Inc. | 10 | $7,719 |
| Acadia Pharmaceuticals Inc | 2 | $5,748 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$35,411
- INVEGA SUSTENNA$110
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.